Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Staphylococcal accessory regulator A (SarA) is a global transcriptional regulator (winged helix DNA-binding protein) in Staphylococcus aureus, including MRSA, that modulates the expression of hundreds of genes involved in virulence, cell wall structure, and biofilm formation. SarA controls key pathogenic processes by both activating and repressing target genes, including those encoding toxins, adhesins, and enzymes relevant to the bacterial response to environmental stress and immune attack. It is critical for MRSA's persistence, especially in the context of biofilm-associated chronic infections and resistance to β-lactam antibiotics. Because of its central role in regulating virulence and resistance, SarA is widely investigated as a therapeutic target, although clinical inhibitors have not yet been established.
Drugs targeting SarA are intended to inhibit its DNA-binding/regulatory function, thereby disrupting regulation of virulence genes and biofilm formation, making MRSA more susceptible to immune clearance or antibiotics
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphylococcal accessory regulator A (SarA).